Uridine triacetate for the treatment of patients exhibiting early onset severe toxicities following 5-fluorouracil or capecitabine administration (all ages)

Document first published:
Page updated:
Topic:
Publication type:

Summary
Uridine triacetate is recommended as a treatment option through routine commissioning for the treatment of patients exhibiting early-onset severe toxicities following 5-fluorouracil or capecitabine administration within the criteria set out in this document.

Document

Uridine triacetate for early onset severe toxicities following 5 fluorouracil or capecitabine administration

Uridine triacetate for early onset severe toxicities following 5 fluorouracil or capecitabine administration

  • PDF
  • 59 KB
  • 5 pages

Document

Rapid Impact Assessment Uridine Triacetate

Rapid Impact Assessment Uridine Triacetate

  • PDF
  • 118 KB
  • 2 pages